Nature vs. nurture revisited--with a whole lot of zeroes at stake.

Look for higher prices ahead for this trio of health care stocks.

The cancer treatment company is a steady grower and priced attractively in a rising market. Grab it.

Hailed as a genius of finance, the former head of AIG helped steer the insurance powerhouse into its present sorry...